Pratteln, Basel-Country, Switzerland
Authentic professional with 15+ years of combined portfolio management and research experience in life sciences. Strong track record in biomedical research in industry and academia. International experience and culturally mindful
- Investigating the function of LRRK2 , Fmr1 and alpha-synuclein - Responsible for the development of a ex-vivo brain slice culture system for modeling neurodegenerative diseases
Investigated the spreading of mutant huntingtin via functional connected cells. Established a novel co-culture system of human derived embryonic stem cells /induced pluripotent stem cells on brain slices for modeling neurodegenerative diseases and drug development.
Analysis of nucleolar involvement in neurodegenerative diseases (e.g. Parkinson’s disease) and aging.
Dissecting nucleolar functions in dopaminergic neurons and Parkinson’s disease by targeted inactivation of the transcription initiation factors IA.“
• Lead project execution after deal closure. Responsible for project initiation, planning, execution and control. • Ensure Customer satisfaction throughout the life of the program in a shared relationship management with KAM/Sales • Responsible for project profitability. • Responsible for delivering to local S&OP and related demand planning • establish mid-to-long term program strategies where applicable (in conjunction with Sales and Commercial Development) • Direct and motivate multi-disciplinary project teams
• Responsible for developing and implementing the scientific strategy for the Brain Health team including hiring and training of new/existing team members and the development of a Operational Masterplan • Installing and maintaining a in vitro neurobiology platform including state-of-the-art technologies • Developing and strengthening partnerships in- and outside of Nestlé to provide information, assistance, and support for various projects • Leading two projects as Project Manager (one with a Proof-of-Concept trial) • Preclinical lead in a Phase III clinical trial